Authors: |
Olova N; Epigenetics Programme, The Babraham Institute, Cambridge, CB22 3AT, UK.; Present address: MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, UK., Krueger F; Bioinformatics Group, The Babraham Institute, Cambridge, CB22 3AT, UK., Andrews S; Bioinformatics Group, The Babraham Institute, Cambridge, CB22 3AT, UK., Oxley D; Mass Spectrometry Facility, The Babraham Institute, Cambridge, CB22 3AT, UK., Berrens RV; Epigenetics Programme, The Babraham Institute, Cambridge, CB22 3AT, UK., Branco MR; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AT, London, UK. m.branco@qmul.ac.uk., Reik W; Epigenetics Programme, The Babraham Institute, Cambridge, CB22 3AT, UK. wolf.reik@babraham.ac.uk.; Wellcome Trust Sanger Institute, Hinxton, CB10 1SA, UK. wolf.reik@babraham.ac.uk.; Centre for Trophoblast Research, University of Cambridge, Cambridge, CB2 3EG, UK. wolf.reik@babraham.ac.uk. |